IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV)

Market Open
5 Dec, 15:36
NYSE NYSE
$
224. 22
-0.7
-0.31%
$
39.47B Market Cap
38.04 P/E Ratio
0% Div Yield
229,677 Volume
10.19 Eps
$ 224.92
Previous Close
Day Range
221.71 226.64
Year Range
134.65 234.3
Want to track IQV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 62 days
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates

IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.64 per share a year ago.

Zacks | 4 months ago
Countdown to IQVIA (IQV) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to IQVIA (IQV) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Get a deeper insight into the potential performance of IQVIA (IQV) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 4 months ago
IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock?

IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock?

IQV is set to report Q2 results on July 22, with both earnings and revenues expected to rise on strong demand across segments.

Zacks | 4 months ago
IQVIA: Competition Is Creating More Challenges Over The Long Haul

IQVIA: Competition Is Creating More Challenges Over The Long Haul

I rate IQVIA as a hold due to long-term competitive threats, particularly from one player, and concerns about capital allocation and high debt. IQVIA's business model is solid, but declining gross margins, low ROIC, and slow innovation raise concerns about its ability to sustain long-term value. The competitor's more innovative, integrated ecosystem and better capital discipline position it to capture market share from IQVIA, especially among small biotechs and large pharma.

Seekingalpha | 4 months ago
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 4 months ago
Why IQVIA Holdings (IQV) is a Top Growth Stock for the Long-Term

Why IQVIA Holdings (IQV) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 4 months ago
Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends

Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends

Evaluate IQVIA's (IQV) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Zacks | 6 months ago
IQVIA: Q1 Earnings Support Steady Optimism

IQVIA: Q1 Earnings Support Steady Optimism

IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, driven by growth in the Technology & Analytics Solutions segment, despite market pessimism. The company's profitability remains robust with adjusted EBITDA of $883M and a 6.3% increase in adjusted EPS, supported by high cash flow conversion. IQVIA's active share repurchase program and raised full-year revenue guidance highlight management's confidence in weathering sector volatility and macroeconomic headwinds.

Seekingalpha | 6 months ago
IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 7 months ago
IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript

IQVIA Holdings Inc. (NYSE:IQV ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations and Treasury Ari Bousbib - Chief Executive Officer Ron Bruehlman - Chief Financial Officer Mike Fedock - Senior Vice President, Financial Planning and Analysis Conference Call Participants Justin Bowers - Deutsche Bank Matthew Sykes - Goldman Sachs Shlomo Rosenbaum - Stifel Financial Corp. Michael Ryskin - Bank of America Jailendra Singh - Truist Securities Eric Coldwell - Robert W. Baird & Co. David Windley - Jefferies Group LLC Tejas Savant - Morgan Stanley Operator Ladies and gentlemen, thank you for standing by.

Seekingalpha | 7 months ago
IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y

IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y

IQV's top line in the first quarter of 2025 benefits from the Research and Development, and Technology and Analytics segments.

Zacks | 7 months ago
IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $2.70 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.54 per share a year ago.

Zacks | 7 months ago
Loading...
Load More